TC-S 7009

1 1

Selleck Chemicals

E1618-5MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
View full details

TC-S 7009 is an inhibitor of HIF used in studies of pathway modulation. In practice, this places the compound in experiments that measure pathway-dependent signal amplification or attenuation in cancer, cell signaling, and epigenetics models.

By inhibiting HIF, TC-S 7009 can be used to examine pathway-dependent signal amplification or attenuation. This target class is commonly examined through pathway-reporter and mechanistic-phenotyping studies, together with downstream-response mapping. In cancer, cell signaling, and epigenetics models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving HIF
  • Concentration-response inhibition and target-dependence studies
  • Pathway-reporter and mechanistic-phenotyping studies
  • Phenotypic profiling in cancer, cell signaling, and epigenetics models

Overall, TC-S 7009 is appropriate when a defined chemical perturbant is needed to connect HIF with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and epigenetics models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
HIF
Target Class:
Signaling Pathway Modulator
Research Area:
Cancer • Cell Signaling • Epigenetics
CAS No.:
1422955-31-4
Molecular Weight:
308.65
Formula:
C₁₂H₆ClFN₄O₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.